Avid Bioservices Inc reports results for the quarter ended in April - Earnings Summary

Avid Bioservices

21/06/2023 22:02

* Avid Bioservices Inc  CDMO.OQ  reported quarterly
breakeven
results​​ per share for the quarter ended in April. The mean
expectation of four analysts for the quarter was for breakeven
results per share.
    * Revenue rose 27.5% to $39.80 million from a year ago;
analysts
expected $38.90 million. 
    * Avid Bioservices Inc's reported EPS for the quarter was
breakeven results​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Avid Bioservices Inc shares had fallen by 14.6% this
quarter and
gained 16.4% so far this year.
    * The company reported a quarterly loss of $309 thousand.
    * Wall Street's median 12-month price target for Avid
Bioservices
Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data June
21 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Apr. 30 2023      0.00           0.00           Met
 Jan. 31 2023      -0.03          0.01           Beat
 Oct. 31 2022      0.00           -0.02          Missed
 Jul. 31 2022      0.04           0.02           Missed